Encompass Health (EHC) EBIT (2009 - 2026)

Encompass Health (EHC) has reported EBIT for 18 consecutive years, with $59.7 million the latest figure, recorded in Q1 2026.

• EBIT for Q1 2026 came in at $59.7 million, up 20.61% year-over-year; the trailing twelve-month figure through Mar 2026 was -$147.2 million (down 236.55% YoY), and the FY2025 annual result was $164.4 million, up 165.59% from the prior year.
• EBIT was $59.7 million for Q1 2026 at Encompass Health, up from -$415.4 million in the prior quarter.
• Over five years, EBIT peaked at $505.9 million in Q4 2023 and troughed at -$415.4 million in Q4 2025.
• Average EBIT over 5 years is $20.7 million, with a median of $12.5 million recorded in 2025.
• Year-over-year, EBIT soared 21185.71% in 2024 and plunged 1703.86% in 2025.
• Over 5 years, EBIT stood at -$342.5 million in 2022, then soared by 247.71% to $505.9 million in 2023, then tumbled by 94.88% to $25.9 million in 2024, then slumped by 1703.86% to -$415.4 million in 2025, then jumped by 114.37% to $59.7 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were $59.7 million in Q1 2026, -$415.4 million in Q4 2025, and $12.5 million in Q3 2025.